Factors influencing the use of opioids for breakthrough cancer pain: a secondary analysis of the IOPS-MS study

Cancer Pain

Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study

J Clin Med.

Mercadante S, Masedu F, Valenti M, Aielli F

doi: 10.3390/jcm9051337.

Cancer Pain

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study

Pain Ther.

Løhre ET, Hjermstad MJ, Brunelli C, Knudsen AK, Kaasa S, Klepstad P

doi: 10.1007/s40122-018-0107-8.

Cancer Pain

A randomised, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids

Eur J Pain.

Currow DC, Clark K, Louw S, Fazekas B, Greene A, Sanderson CR

doi: 10.1002/ejp.1548.

COMMENTED

Cancer Pain

Effect of opioid exposure on efficacy and tolerability of sublingual fentanyl and subcutaneous morphine for severe cancer pain episodes. Secondary analysis from a double-blind double-dummy, randomized trial

J Pain Symptom Manage.

Ricchini F, Caraceni A, Zecca E, Pigni A, Centurioni F, Manzoni A, Kaasa S, Brunelli C

doi: 10.1016/

COMMENTED

Cancer PainPain ManagementPain Relief

Effects of the OPRM1 A118G Polymorphism(rs1799971) on Opioids Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis

Clin J Pain.

Yu ZC, Wen L, Shen XY, Zhang HM

doi: 10.1097/AJP.

Cancer PainPain Relief

A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study

J Clin Med

Mercadante S, Caraceni A, Cuomo A, Mammucari M, Marchetti P, Mediati RD, Natoli S, Tonini G

doi: 10.3390/jcm10112273

Chronic Pain

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Pain.

Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC

doi: 10.1097/

COMMENTED

Chronic Pain

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

Lancet Public Health.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L

doi: 10.1016/S2468-2667

RECOMMENDED

Acute PainPostoperative Pain

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study

Reg Anesth Pain Med.

Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S

doi: 10.1136/rapm-2018-000040.

Related content

Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study

A randomised, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids

Effect of opioid exposure on efficacy and tolerability of sublingual fentanyl and subcutaneous morphine for severe cancer pain episodes. Secondary analysis from a double-blind double-dummy, randomized trial

Effects of the OPRM1 A118G Polymorphism(rs1799971) on Opioids Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis

A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study